Based on this evaluation, a personalized peptide protocol can be recommended
NIH summarizes evidence linking higher TMAO with cardiovascular risk, while also noting that the implications are not fully understood
They function by mimicking hormones that regulate appetite and food intake
Again, GLP-1(2836) did not affect mitochondrial glucose oxidation under the high-glucose concentrations used in the siRNA transfections (Figure 7E)
GLP-1 medications can cause side effects such as nausea, constipation, fatigue, reflux, or appetite changes, especially during dose escalation
Peptides can be used topically or through medical peptide therapy to support density and long-term regrowth